| 000 | 00905 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517194717.0 | ||
| 264 | 0 | _c20180912 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1365-2516 | ||
| 024 | 7 |
_a10.1111/hae.13380 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThomas, A E | |
| 245 | 0 | 0 |
_aBiosimilars and haemophilia. _h[electronic resource] |
| 260 |
_bHaemophilia : the official journal of the World Federation of Hemophilia _c01 2018 |
||
| 300 |
_a17-19 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aBiosimilar Pharmaceuticals _xtherapeutic use |
| 650 | 0 | 4 |
_aHemophilia A _xdrug therapy |
| 650 | 0 | 4 |
_aHemophilia B _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tHaemophilia : the official journal of the World Federation of Hemophilia _gvol. 24 _gno. 1 _gp. 17-19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/hae.13380 _zAvailable from publisher's website |
| 999 |
_c27987163 _d27987163 |
||